"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”
A trial looking at a new way to help diagnose lung cancer
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
This trial looked at a computer model called ‘fuzzy logic’ to see if it can help diagnose lung cancer.
More about this trial
There are different tests to diagnose lung cancer, including:
- looking for cancer cells in a sample of sputum or lung tissue (histology)
- scans such as a chest X-ray or CT scan
- testing blood samples
But some of these tests are invasive and doctors are keen to find other ways of diagnosing lung cancer. One way is to look more closely at blood samples.
Tumour markers are substances produced by cancer cells and found in the blood. Doctors hoped to put lots of information about different tumour markers into the ‘fuzzy logic’ computer programme. They wanted to see any patterns linking certain markers to certain lung cancers. They hoped this would help to diagnose lung cancer more accurately in future.
Summary of results
The trial team have told us that it is unlikely they will publish the results of this trial. This is because since the trial closed technology has moved on and so their results will be out of date.
How to join a clinical trial
Professor Paul Lorigan
Experimental Cancer Medicine Centre (ECMC)
MeDis Research Ltd